Trade ADMA Biologics, Inc. - ADMA CFD
What is ADMA Biologics, Inc. (ADMA)?
ADMA Biologics, Inc. is a biopharmaceutical company engaged in the development, manufacturing, and commercialization of specialty plasma-derived biologics. The company focuses on therapies that address immune deficiencies and infectious diseases. ADMA Biologics produces intravenous immunoglobulin products designed to enhance immune response in patients with compromised immune systems. Its manufacturing facilities comply with regulatory standards for plasma collection and biologics production. The company’s portfolio includes products intended for both hospital and outpatient settings. ADMA Biologics operates within the healthcare industry, contributing to treatments that support immune health. Its efforts include research and development activities aimed at expanding therapeutic options for patients with immune-related conditions.
ADMA Biologics, Inc. Stock Price Today: Live Overview
The price today is shaped by active market pricing, as ADMA Biologics, Inc. trades at $9.1396. It has ranged from $8.9204 to $9.5504 during the session, with a daily percentage change of +1.0022%.
FAQ: ADMA Biologics, Inc. (ADMA)
What is the current price of ADMA stock?
The current trading price is $9.1396.
Does ADMA pay dividends?
ADMA Biologics, Inc. does not pay dividends.
Does ADMA have a formal corporate presence or regional headquarters in the UAE?
ADMA Biologics, Inc. operates in the UAE through distributors without an official regional office or subsidiary.
What is ADMA best known for?
ADMA Biologics, Inc. is most famous for its development of plasma-derived biologics for immune deficiencies.
What assets are typically shown together with ADMA?
Commonly shown alongside ADMA: Shangri-La Asia, Schwab Fundamental Emerging Markets Equity ETF, The Ensign Group Inc
Latest shares articles



